Capture Vascular | Patents
17613
page,page-id-17613,page-template,page-template-full_width,page-template-full_width-php,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Intellectual Property and Regulatory Strategy

Capture Vascular’s technology has a strong portfolio of intellectual property with freedom
to operate and has employed a multipronged and aggressive patent strategy with
Wilson Sonsini Goodrich & Rosati (Palo Alto, California) to further expand the already
extensive intellectual property portfolio. Below is a listing of our patients and
applications that provide patent protection until 2032.

  • Patent or Application #

  • $0/mo
    • US Pat. No. 9,186,487
    • US Pat. No. 9,126,016
    • US Pat. No. 6,699,260
    • US Pat. No. 6,221,006
    • US Pat. No. 6,238,412
    • US Pat. No. 6,695,858
    • US Pat. No. 6,258,115
    • US Pat. No. 6,635,068

     

    • Patent Cooperation Treaty WO 2015/187196 PCT/US 2014/0679696
    • Japan 2006-510058 Japan Pat. No. 4731471
    • Japan Pat. No. 5805736
    • US Pat. Application No. 13/190,416
    • US Pat. Application No. 14/201,371
    • US Pat. Application No. 14/554,348
    • US Pat. Application No. 14/645,830
    • European Patent Convention 04759873.5

     

  • Title

  • $0/mo
    • Medical Device and Method
    • Augmented Delivery Catheter and Method
    • Tissue Removal Device and Method
    • Entrapping Apparatus and Method For Use
    • Biological Passageway Occlusion Removal
    • Medical Device and Methods For Use
    • Bifurcated Stent and Distal Protection System
    • Occlusion, Anchoring, Tensioning, and Flow Directed Apparatus and Methods
    • Low Radial Force Vascular Device and
      Method of Occlusion
    • Medical Device and Method
    • Medical Device and Method
    • Devices and Methods for Treating Venous Diseases
    • Medical Device and Method
    • Low Radial Vascular Device and Method of Occlusion
    • Low Radial Vascular Device and Method of Occlusion
    • Medical Device and Method

  • Devices

  • $0/mo
    • MegaVac
    • MegaVac
    • MegaVac / ThromboWire
    • MegaVac / ThromboWire
    • MegaVac / ThromboWire
    • MegaVac / ThromboWire
    • ThromboWire
    • ThromboWire

     

    • MegaVac / ThromboWire

     

    • MegaVac / ThromboWire
    • MegaVac
    • MegaVac / ThromboWire
    • MegaVac / ThromboWire
    • MegaVac / ThromboWire
    • MegaVac / ThromboWire
    • MegaVac / ThromboWire

Regulatory Strategy

MegaVac and ThromboWire have already achieved FDA 510(k)-clearance,
both as a system (K040010) and as individual stand-alone devices (K092623).
Capture Vascular has obtained a worldwide exclusive license for the technology
in the fields of thrombectomy and embolic protection.
Both 510(k) clearances have the following indications:


The non-surgical removal of emboli and thrombi from blood vessels



The non-surgical removal of thrombi from synthetic grafts



Use in temporary blood vessel/graft occlusion



Injection, infusion, and/or aspiration of contrast media and other fluids into or from a vessel/graft



Catheter placement over a guidewire